CorMedix Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
Forward P/E12.27
P/S Ratio11.312662.04907.08997.29
P/B Ratio5.812.943.162.765.39
Price/Tangible Book5.932.943.162.765.39
Enterprise Value Ratios
EV/Revenue10.261772.75535.14846.85
Profitability & Returns
Return on Equity (ROE)-0.23%-0.74%-0.50%-0.53%-0.65%
Return on Assets (ROA)-0.14%-0.42%-0.29%-0.31%-0.43%
Return on Capital Employed (ROCE)-0.26%-0.69%-0.55%-0.46%-0.60%
Leverage & Solvency Ratios
Debt/Equity0.010.010.010.010.02
Liquidity Ratios
Current Ratio3.396.979.4412.4411.58
Quick Ratio3.056.679.3212.2611.14
Efficiency Ratios
Asset Turnover0.430.000.000.01
Inventory Turnover0.662.030.85
Yield & Distribution Ratios
Earnings Yield-0.04%-0.22%-0.17%-0.16%-0.09%
FCF Yield-0.10%-0.19%-0.14%-0.13%-0.09%
Buyback Yield-0.16%-0.26%-0.07%-0.32%-0.18%